Teladoc Health Sees Q3 GAAP EPS $(0.30)-$(0.20) vs $(0.18) Est; Sees Sales $569.000M-$609.000M vs $629.252M Est

Benzinga Newsdesk www.benzinga.com Neutral 46.1%

Neg 0% Neu 46.1% Pos 0%

Teladoc Health (NYSE:TDOC) is looking for Q3 GAAP EPS of $(0.30)-$(0.20) vs $(0.18) analyst estimate. sees sales of $569.000 million-$609.000 million vs $629.252 million analyst estimate.